Skip to main content

Cheap Low Calorie Diets For Weight Loss


The Low-calorie Diet (LCD) 
 A typical LCD may provide „ 1,000–1,200 calories/day for a woman „ 1,200–1,600 calories/day for a man
The number of calories may be adjusted based on your age, weight, and how active you are. An LCD usually consists of regular foods, but could also include meal replacements.

As a result, you may find this type of diet much easier to follow than a VLCD. In the long term, LCDs have been found to lead to the same amount of weight loss as VLCDs.


What is a VLCD?
A VLCD is a special diet that provides up to 800 calories per day. VLCDs use commercial formulas,
usually liquid shakes, soups, or bars, which replace all your regular meals. These formulas are not the
same as the meal replacements you can find at grocery stores or pharmacies, which are meant to
replace one or two meals a day.

Depending on a number of factors, healthy adults need different amounts of calories to meet their
daily energy needs. A standard amount is about 2,000 calories. VLCDs provide far fewer calories
than most people need to maintain a healthy weight. This type of diet is used to promote quick
weight loss, often as a way to jump-start an obesity treatment program.

VLCD formulas are designed to provide all of the nutrients you need while helping you lose weight
quickly. However, this type of diet should only be used for a short time—usually about 12 weeks.


Since VLCD needs clinical supervision given the risks, you are strongly advised not to go on a VLCD on your own. If you need to lose weight, and considering an affordable, VLCD program for weight loss, you may want to consider W8MD.
Cost of W8MD VLCD Meal Replacement Program
Costing as little as $2.15 per meal replaced, with our delicious and affordable meal replacement products, you can not only lose weight but potentially save on grocery bills as even the grocery ingredients cost a bit more according to the research from our manufacturer.
Choose between 4 or 5 partial meal replacements along with 1-2 of your own meals with printed detailed instructions on 800 calorie VLCD diet so you can lose weight safely and effectively.
It is believed that the average cost of grocery ingredients can be up to $2.50 not counting the time it takes to prepare the meals. On the other hand, W8MD’s VLCD meal replacement plans can help you lose weight at the same time as saving up to 15 percent on your grocery bills depending on how much you spend on groceries.


Call W8MD at 1(800)986-3007 (W8MD-007) to learn more.
Multiple locations in Greater Philadelphia, New York City and other places.
Visit http://www.w8md.com for more information


W8MD’s Philadelphia Insurance Weight
Loss, Sleep & MedSpa Center
1718, Welsh Rd,
Philadelphia, PA, 19115
P: 215-676-2334
W8MD’s King Of Prussia Weight
Loss, Sleep & MedSpa
987 Old Eagle School Rd, Ste 712
Wayne, PA, 19087
P: 215-676-2334
W8MD’s NYC Insurance Weight
Loss, Sleep & MedSpa
2632 E 21st Street Ste. L2
Brooklyn, NY 11235
P: 718-946-5500
W8MD Weight Loss, Sleep & MedSpa
140 E. Evesham Road, Cherry Hill, NJ
(Grand Opening in Jan 2019)
P: 800-W8MD-007.

Comments

Popular posts from this blog

What you need to know about new weight loss medication Belviq

After a long gap of over 13 years, the FDA started approving new weight loss medications beginning with Belviq approved in June of 2012 and Qsymia approved in July 2012. After a gap of another 2 years, the FDA approved two new weight loss medications in late 2014 with Contrave approved in September and Saxenda in December. Let us review these 4 new weight loss medications and compare their relative utility in helping one lose weight!


First new weight loss drug - Belviq 

Of the four new weight loss drugs, Belviq is probably one of the safest albeit not the most potent! Since it is not a stimulant type medication, it can safely be used even in those that have had a prior history of certain cardiovascular problems in the remote past including coronary artery disease.


When was Belviq approved for weight loss?

The U.S. approved Belviq (lorcaserin hydrochloride), in June of 2012 in addition to a reduced-calorie diet and exercise, for chronic weight management.


What are the indications for Bel…

Prediabetes and diabetes

The Epidemic of Prediabetes and Diabetes!
According to a new study, investigators say diabetes and prediabetes will also account for an estimated 10 percent of total health care spending by the end of the decade at an annual cost of almost $500 billion. That's up from an estimated $194 billion in 2010.

The report, "The United States of Diabetes: Challenges and Opportunities in the Decade Ahead," was unveiled this week, because November is National Diabetes Prevention month. The study offers solutions designed to improve health and life expectancy, while also saving up to $250 billion over the next 10 years.

Read this report on CNN titled Diabetes or prediabetes predicted for half of Americans by 2020

What is Prediabetes and why is it important to reverse it for weight loss, and prevention of diabetes?Prediabetes is a serious health condition that increases the risk of developing type 2 diabetes, heart disease, and stroke. Yet the vast majority of people with prediabetes do …

Belviq weight loss doctor Philadelphia

The new weight loss medication, Belviq, will be available for obesity treatment from 06/11/2013 and W8MD Medical Weight Loss Centers weight loss physicians in New York City, and Philadelphia help.

More than one-third of U.S. adults are obese, and obesity contributes to a number of health conditions, including high blood pressure, type 2 diabetes, and high cholesterol.

To help obese and overweight Americans who have been unsuccessful in getting their weight under control with diet and exercise, the Food and Drug Administration (FDA) has approved two new medications—the first drugs for long-term weight management that FDA has approved in 13 years.

Marketed as Belviq and Qsymia, these prescription medications would be taken for the rest of a person’s life. “For many people, obesity is a lifelong condition, but we don’t always think of it—or treat it—as such,” says Amy Egan, M.D., M.P.H., deputy director for safety in FDA’s Division of Metabolism and Endocrinology Products (DMEP).

“Qsymi…